参考文献
1: Delgado-Montero A, Zamorano JL. Atorvastatin calcium plus amlodipine for the treatment of hypertension. Expert Opin Pharmacother. 2012 Dec;13(18):2673-85. doi: 10.1517/14656566.2012.742064. Review. PubMed PMID: 23140185.
2: Goriacko P, Andersen M, Fazylov R, Plakogiannis R. What Is the Appropriate Duration of High-Dose Atorvastatin Therapy Post-Acute Coronary Syndrome? J Pharm Pract. 2015 Dec;28(6):555-60. Review. PubMed PMID: 25107416.
3: Karlson BW, Palmer MK, Nicholls SJ, Lundman P, Barter PJ. Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis. Eur J Prev Cardiol. 2016 May;23(7):744-7. doi: 10.1177/2047487315598710. Review. PubMed PMID: 26246463.
4: Li H, Wang C, Zhang S, Sun S, Li R, Zou M, Cheng G. Safety Profile of Atorvastatin 80 mg: A Meta-Analysis of 17 Randomized Controlled Trials in 21,910 Participants. Drug Saf. 2016 May;39(5):409-19. doi: 10.1007/s40264-016-0394-0. Review. PubMed PMID: 26860922.
5: Fang N, Han W, Gong D, Zou Chen, Fan Y. Atorvastatin Treatment for Carotid Intima-Media Thickness in Chinese Patients With Type 2 Diabetes: A Meta-Analysis. Medicine (Baltimore). 2015 Nov;94(44):e1920. doi: 10.1097/MD.0000000000001920. Review. PubMed PMID: 26554793; PubMed Central PMCID: PMC4915894.
6: Qian C, Wei B, Ding J, Wu H, Cai X, Li B, Wang Y. Meta-analysis comparing the effects of rosuvastatin versus atorvastatin on regression of coronary atherosclerotic plaques. Am J Cardiol. 2015 Nov 15;116(10):1521-6. doi: 10.1016/j.amjcard.2015.08.010. Review. PubMed PMID: 26385518.
7: Blank R. A single-pill combination of amlodipine besylate and atorvastatin calcium. Drugs Today (Barc). 2006 Mar;42(3):157-75. Review. PubMed PMID: 16628258.
8: Adams SP, Tsang M, Wright JM. Lipid-lowering efficacy of atorvastatin. Cochrane Database Syst Rev. 2015 Mar 12;(3):CD008226. doi: 10.1002/14651858.CD008226.pub3. Review. PubMed PMID: 25760954.
9: Ye YC, Zhao XL, Zhang SY. Use of atorvastatin in lipid disorders and cardiovascular disease in Chinese patients. Chin Med J (Engl). 2015 Jan 20;128(2):259-66. doi: 10.4103/0366-6999.149226. Review. PubMed PMID: 25591572; PubMed Central PMCID: PMC4837848.
10: Dai G, Xu Q, Luo R, Gao J, Chen H, Deng Y, Li Y, Wang Y, Yuan W, Wu X. Atorvastatin treatment improves effects of implanted mesenchymal stem cells: meta-analysis of animal models with acute myocardial infarction. BMC Cardiovasc Disord. 2015 Dec 14;15:170. doi: 10.1186/s12872-015-0162-6. Review. PubMed PMID: 26667804; PubMed Central PMCID: PMC4678482.
11: Takagi H, Niwa M, Mizuno Y, Yamamoto H, Goto SN, Umemoto T. Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials. Heart Vessels. 2014 May;29(3):287-99. doi: 10.1007/s00380-013-0358-6. Review. PubMed PMID: 23644555.
12: Takagi H, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group.. A meta-analysis of randomized head-to-head trials for effects of rosuvastatin versus atorvastatin on apolipoprotein profiles. Am J Cardiol. 2014 Jan 15;113(2):292-301. doi: 10.1016/j.amjcard.2013.08.043. Review. PubMed PMID: 24230979.
13: Yang Q, Qi X, Li Y. The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2014 Aug 13;14:99. doi: 10.1186/1471-2261-14-99. Review. PubMed PMID: 25117689; PubMed Central PMCID: PMC4135360.
14: Simoens S, Sinnaeve PR. Generic atorvastatin, the Belgian statin market and the cost-effectiveness of statin therapy. Cardiovasc Drugs Ther. 2013 Feb;27(1):49-60. doi: 10.1007/s10557-012-6432-y. Review. PubMed PMID: 23242669.
15: Adams SP, Tsang M, Wright JM. Lipid lowering efficacy of atorvastatin. Cochrane Database Syst Rev. 2012 Dec 12;12:CD008226. doi: 10.1002/14651858.CD008226.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;3:CD008226. PubMed PMID: 23235655.
16: Violi F, Carnevale R, Pastori D, Pignatelli P. Antioxidant and antiplatelet effects of atorvastatin by Nox2 inhibition. Trends Cardiovasc Med. 2014 May;24(4):142-8. doi: 10.1016/j.tcm.2013.09.006. Review. PubMed PMID: 24263084.
17: Poolsup N, Suksomboon N, Wongyaowarat K, Rungkanchananon B, Niyomrat P, Kongsuwan S. Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia. J Clin Pharm Ther. 2012 Apr;37(2):166-72. doi: 10.1111/j.1365-2710.2011.01274.x. Review. PubMed PMID: 21585411.
18: Liu M, Alafris A, Longo AJ, Cohen H. Irreversible atorvastatin-associated hearing loss. Pharmacotherapy. 2012 Feb;32(2):e27-34. doi: 10.1002/PHAR.1040. Review. PubMed PMID: 22392429.
19: McKenney JM. Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature review. Postgrad Med. 2012 Jan;124(1):7-20. doi: 10.3810/pgm.2012.01.2513. Review. PubMed PMID: 22314110.
20: DiNicolantonio JJ, Lavie CJ, Serebruany VL, O'Keefe JH. Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease. Postgrad Med. 2013 Jan;125(1):7-16. doi: 10.3810/pgm.2013.01.2620. Review. PubMed PMID: 23391667.
